The Effects of Lemon Essential Oil Inhalation on Attention in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Lemon Essential Oil Inhalation Improves Sustained Attention in Children With Attention-Deficit/Hyperactivity Disorder: A Placebo-Controlled Trial
1 other identifier
interventional
52
1 country
1
Brief Summary
This randomized, placebo-controlled clinical trial aims to evaluate the acute effects of lemon essential oil inhalation on sustained attention and visual memory in children diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). Fifty-two medication-naive children aged 9-16 were randomized to receive either lemon oil or placebo inhalation before cognitive assessments. Primary outcome was sustained attention performance. The study found significant improvements in attention scores in the lemon oil group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedFirst Submitted
Initial submission to the registry
December 24, 2025
CompletedFirst Posted
Study publicly available on registry
May 14, 2026
CompletedMay 14, 2026
December 1, 2025
1.6 years
December 24, 2025
May 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in D2 Attention Test Total Performance Score (TN-E)
The D2 Attention Test evaluates sustained attention and concentration performance. The TN-E (Total Number of Correct Items minus Errors) score reflects attentional capacity. A higher post-intervention TN-E score indicates improved attention. The difference between baseline and Day 30 scores will be compared between the lemon essential oil group and placebo group.
Baseline and Day 30 (after intervention)
Secondary Outcomes (1)
Change in Benton Visual Retention Test (BVRT) Score
Baseline and Day 30 (after intervention)
Study Arms (2)
Lemon Essential Oil Inhalation (LEO)
EXPERIMENTALParticipants in this arm received a single-session inhalation of 100% pure lemon essential oil (Citrus limon) via a sterile cotton pad. Five drops of essential oil were applied to the pad, which was held approximately 5 cm from the participant's nose. The child inhaled the scent for 5 minutes under supervision in a clinical setting. Neuropsychological testing (D2 Attention Test and Benton Visual Memory Test) followed immediately after inhalation.
Placebo Inhalation (Distilled Water)
PLACEBO COMPARATORParticipants in this arm received a single-session inhalation of distilled water as placebo. Five drops of distilled water were applied to a sterile cotton pad, which was held approximately 5 cm from the participant's nose. The child inhaled the scentless solution for 5 minutes under supervision. Neuropsychological testing (D2 Attention Test and Benton Visual Memory Test) followed immediately after inhalation.
Interventions
This intervention consists of a single-session, short-term olfactory exposure to 100% pure lemon essential oil (Citrus limon, ISO 9235 compliant, GC-MS confirmed composition: limonene 67.2%, β-pinene 12.3%, γ-terpinene 9.8%). Five drops were applied to a sterile cotton pad and held approximately 5 cm from the participant's nose. Participants inhaled the aroma for 5 minutes under direct supervision in a quiet, odor-free clinical setting. This intervention was administered immediately prior to standardized neuropsychological assessments measuring attention and visual memory. No ingestion or topical application occurred.
The placebo condition involved the same protocol as the intervention group, using five drops of distilled water applied to a sterile cotton pad. The pad was held approximately 5 cm from the participant's nose, and inhalation lasted for 5 minutes. The procedure was designed to mimic the intervention without olfactory stimulation, ensuring consistency in timing, setting, and administration method.
Eligibility Criteria
You may qualify if:
- Children aged 9 to 16 years
- Diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) based on DSM-5 criteria
- Medication-naive (not currently using or previously treated with pharmacological agents for ADHD)
- No chronic medical or psychiatric comorbidities
- Capable of completing standardized cognitive assessments (e.g., D2 Attention Test, Benton Visual Memory Test)
- Written informed consent obtained from a parent or legal guardian
- Written assent obtained from the child
You may not qualify if:
- Lack of written parental consent or child assent
- Inability to comply with the study protocol (e.g., refusal to complete cognitive testing or intervention procedure)
- Current or prior use of ADHD medication
- Presence of moderate-to-severe ADHD symptoms requiring immediate pharmacological treatment (based on AACAP 2020 and NICE 2019 guidelines)
- Presence of any chronic medical or psychiatric comorbid condition
- Diagnosis not confirmed by a board-certified child and adolescent psychiatrist
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Basaksehir Cam ve Sakura City Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 24, 2025
First Posted
May 14, 2026
Study Start
February 15, 2022
Primary Completion
September 30, 2023
Study Completion
September 30, 2023
Last Updated
May 14, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared for this study due to ethical considerations, privacy protection regulations involving minors, and the absence of prior consent for data sharing beyond the scope of this trial. Additionally, the study was conducted with a small sample size from a single center, limiting the generalizability and reuse of anonymized data for broader analysis.